The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 6,324,500 | 350,000 | SH | DFND | 1,2 | 0 | 350,000 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 20,134,195 | 1,941,581 | SH | DFND | 1,2 | 0 | 1,941,581 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 2,644,350 | 255,000 | SH | Put | DFND | 1,2 | 0 | 255,000 | 0 | |
ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | 5,056,594 | 1,051,267 | SH | DFND | 1,2 | 0 | 1,051,267 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 15,986,510 | 932,158 | SH | DFND | 1,2 | 0 | 932,158 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 12,878,479 | 411,453 | SH | DFND | 1,2 | 0 | 411,453 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 34,578,713 | 3,363,688 | SH | DFND | 1,2 | 0 | 3,363,688 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 8,809,484 | 701,392 | SH | DFND | 1,2 | 0 | 701,392 | 0 | ||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 20,896,908 | 968,795 | SH | DFND | 1,2 | 0 | 968,795 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 18,190,733 | 894,333 | SH | DFND | 1,2 | 0 | 894,333 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 8,627,170 | 94,700 | SH | Put | DFND | 1,2 | 0 | 94,700 | 0 | |
ARCELLX INC | COMMON STOCK | 03940C100 | 1,185,750 | 37,500 | SH | DFND | 1,2 | 0 | 37,500 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 19,572,000 | 600,000 | SH | DFND | 1,2 | 0 | 600,000 | 0 | ||
EVOLUS INC | COM | 30052C107 | 17,695,529 | 2,434,048 | SH | DFND | 1,2 | 0 | 2,434,048 | 0 | ||
GENERATION BIO CO | COM | 37148K100 | 5,623,954 | 1,022,537 | SH | DFND | 1,2 | 0 | 1,022,537 | 0 | ||
GRACELL BIOTECHNOLOGIES INC | SPONSORED ADS | 38406L103 | 8,641,297 | 2,268,057 | SH | DFND | 1,2 | 0 | 2,268,057 | 0 | ||
HERON THERAPEUTICS INC | COM | 427746102 | 5,495,347 | 4,737,368 | SH | DFND | 1,2 | 0 | 4,737,368 | 0 | ||
IGM BIOSCIENCES INC | COM | 449585108 | 4,615,000 | 500,000 | SH | DFND | 1,2 | 0 | 500,000 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 17,813,037 | 297,082 | SH | DFND | 1,2 | 0 | 297,082 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 6,650,621 | 601,322 | SH | DFND | 1,2 | 0 | 601,322 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 230,300 | 70,000 | SH | Call | DFND | 1,2 | 0 | 70,000 | 0 | |
MINERALYS THERAPEUTICS INC | COM | 603170101 | 9,310,306 | 546,059 | SH | DFND | 1,2 | 0 | 546,059 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 10,873,125 | 8,839,939 | SH | DFND | 1,2 | 0 | 8,839,939 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 28,089,334 | 1,550,184 | SH | DFND | 1,2 | 0 | 1,550,184 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 27,180,000 | 3,000,000 | SH | DFND | 1,2 | 0 | 3,000,000 | 0 | ||
PRECISION BIOSCIENCES INC | COM | 74019P108 | 3,929,081 | 7,469,736 | SH | DFND | 1,2 | 0 | 7,469,736 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 27,398,324 | 1,465,151 | SH | DFND | 1,2 | 0 | 1,465,151 | 0 | ||
RENEO PHARMACEUTICALS INC | COM | 75974E103 | 7,106,560 | 1,083,317 | SH | DFND | 1,2 | 0 | 1,083,317 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 12,730,280 | 772,000 | SH | DFND | 1,2 | 0 | 772,000 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 14,154,672 | 123,600 | SH | DFND | 1,2 | 0 | 123,600 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | 4,493,341 | 938,067 | SH | DFND | 1,2 | 0 | 938,067 | 0 | ||
SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 3,062,560 | 584,458 | SH | DFND | 1,2 | 0 | 584,458 | 0 | ||
TALARIS THERAPEUTICS INC | COM | 87410C104 | 2,024,740 | 666,033 | SH | DFND | 1,2 | 0 | 666,033 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 921,600 | 60,000 | SH | DFND | 1,2 | 0 | 60,000 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 31,249,661 | 677,426 | SH | DFND | 1,2 | 0 | 677,426 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 29,425,197 | 589,211 | SH | DFND | 1,2 | 0 | 589,211 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 9,702,496 | 598,550 | SH | DFND | 1,2 | 0 | 598,550 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 20,405,000 | 530,000 | SH | DFND | 1,2 | 0 | 530,000 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 103,950 | 2,700 | SH | Put | DFND | 1,2 | 0 | 2,700 | 0 | |
ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 27,019,000 | 3,295,000 | SH | DFND | 1,2 | 0 | 3,295,000 | 0 |